1608
600
previou
niessen
student
sci
genetic
gram
alauddin
150
multiple
adjusted
1581
atom
nai
deadly
kitamura
measured
sulfite
1420
overly
DIPEA
germany
IU
licensee
H1975
yanamoto
san
acylation
acetone
time
pal
1709
181
doe
hydrochloric
basi
remain
third
1686
270
wakelee
diagnostic
156
acryloyl
step
MS
ratio
kim
graduate
differential
smit
100
lower
chemical
torre
pretreatment
burden
made
124
hitachi
houston
scientific
H9
seeded
pao
shiba
spectroscopy
monitoring
SPECT
mater
pyrimidin
activitie
gamma
very
statistical
C7
level
hydroxyacetophenone
part
therapeutic
benzo
after
derek
required
why
T100TD
NSCLC
kimura
spleen
drug
comparison
song
xiao
witsuba
nitrite
123
sufficient
positron
however
S29
nitrogen
acidic
fundamental
available
334
successively
new
cosmosil
anuradha
week
inhibition
dicarbonate
white
starting
active
radiotheranostic
marjani
CO
maximal
yuan
indicate
such
xenograft
signaling
gumerlock
supported
366
effect
phelp
HRMS
role
vijayavardhini
141
inhibit
TK
optical
H19
TLC
residue
software
pharm
hamamoto
tumor
suitable
block
263
RP
oxidizing
resistance
S1
enzymatic
JCF
relationship
ECS
agent
half
diazonium
countrie
8640
well
chemoselective
celite
eur
animal
goldman
chen
5585
branched
strength
waaijer
corresponding
kidney
concerning
work
462
schopf
1640
fece
clf3
supposed
expressed
overcome
detect
mhz
laboratory
carcinoma
soerjomataram
activating
1613
EGFRT790M
iressa
izumi
ferl
added
118
CH3
BALB
II
accorded
tel
mccoy
angiogenesi
heterogeneity
selection
BCA
palladium
lub
imaging
MDPI
passed
knowledge
WT
identified
parra
addition
universita
phase
mol
potassium
MSII
peng
S9
metastatic
izumisw
fetal
personalized
table
okuda
occurring
dichloride
749
sjin
direct
corp
3390
albumin
membrane
preclinical
diaminopyrimidine
9880
maeda
accumulation
statu
2011
via
shake
clearance
next
weighed
haringsma
associate
ability
metal
PBS
radioiodine
oxnard
wang
flow
sufficiently
specimen
seigo
108
yamasaki
TECAN
nonsmall
june
orange
arimitsu
pale
outcome
237
bicarbonate
male
editing
contribute
681
siegel
identity
N7
0345
filtered
53517
supervision
survival
0001
38803
piperidin
use
chelation
pressure
laurent
either
log
3121
chromatogram
GLOBOCAN
2010
miyawaki
their
assessment
antitumor
105
declared
DPPY
toyoshima
layer
juri
old
effectively
prepare
845
accepted
S13
therefore
expression
hardly
shen
mori
methoxy
726
initial
140
how
resource
order
ballard
106
sensitivity
128
necessary
riely
malignant
examined
tin
1153
radiochemical
transferred
radiotracer
DMA
USA
alternative
rao
intravenously
frequent
synthesi
invention
main
shaken
fujifilm
FBS
solid
1415
prefer
nacalai
umol
163
small
aniline
www
adenosine
gassing
C27
hamamatsu
2009
164
online
worldwide
setting
234
inc
read
149
open
0331
difficult
short
interfere
sun
yang
diagnosi
comparing
enhance
supernatant
attribution
omega
tail
1609
intratumor
caused
pph3
solution
unclear
including
situ
advance
hickey
eventually
vial
dark
non
1031
approach
technology
rizzo
hydrogen
forming
HYNIC
180
scheme
way
capelletti
QST
bond
nucl
development
spectra
gandara
sncl2
schuit
crosslinker
behave
peptide
tetrazolium
hexane
article
384
fahr
significant
FDA
structural
gonzalez
milligram
diaminophenyl
110
ethyl
followed
boc2
provide
graphpad
stirred
instability
approval
testa
1295
metastase
intracellular
before
milliliter
chiba
phenyl
yin
exposure
accounting
nishii
lepera
suboptimal
indicating
twice
mdpi
ethan
copy
SO
incubation
longer
reflect
determined
shimadzu
org
type
core
surfactant
nano2
treated
coefficient
education
brain
determination
divided
PEG
ishioka
hirata
providing
committee
model
discov
appropriate
pdcl2
varga
five
NH
tukey
great
KI
characterization
acknowledge
decrease
formation
molecules25122914
explanation
eliminated
C13
show
but
impressive
radioactivity
improving
indeed
standard
analyzed
119
probe
jemal
colucci
chloride
PEG3
acetylpiperazin
185
H4
makino
erlotinib
similar
flore
RGD
system
saturated
haumann
hsu
pigmented
nuclear
analysi
humidified
portion
HPLC
experimental
positive
purple
modulator
kang
darmstadt
chloro
5576
using
IPQA
1099
BUDI
associated
green
harbor
agonist
wei
preci
853
LN
pro
biopsie
formal
nitrophenol
water
arai
affect
2012
comparable
tong
tesque
9654
2007
derivative
dramatically
H12
spaeth
medicine
triphenylphosphine
amine
accumulate
hirsch
trypsin
rev
did
charged
carbon
writing
1700
sty
na2
validation
H27
bombardment
manufacturer
general
our
substituent
miyazaki
dinitroaniline
walsum
shinohara
ddy
salt
prolonged
research
6359
4460
40740
bicinchoninic
tiny
anticipated
science
light
supporting
3436
young
corporation
preparation
ha
http
169
takeda
thorac
interest
kri
mean
fund
catalyzed
inhibited
seamu
decomposed
519
reflux
versu
1550
butyl
flask
study
classification
counting
dose
piperazine
kazuma
sawazaki
between
infinite
increase
adamo
santini
hypothesized
performed
K2
ladanyi
cantarini
deletion
separate
jin
school
van
conducive
962
ther
quin
mukhapadhyay
who
reference
gene
2016
urine
analyse
kyoto
excreted
continuou
luminescence
relatively
kai
respective
insertion
liquid
enomoto
engl
papadimitrakopoulou
seem
gbq
life
DMEM
basel
outlined
pubmed
1477
eagle
neutral
diego
today
scholarship
paglia
visualize
penicillin
post
148
carbonate
PET
296
large
room
initiative
containing
disease
manuscript
immunohistochemistry
estimate
trial
related
treat
advanced
rapid
methionine
complete
brine
contribution
single
aqueou
O3
SD
respectively
chromatography
almutairi
conversely
zakowski
acquisition
might
gelovani
key
precision
author
tokyo
useful
NMR
solca
improve
111
medium
original
region
invasive
L858R
dinitrobenzene
0949
due
9216
yui
ID
takai
pore
female
167
density
IRS
photon
AL
chloroform
pan
gradient
anilinopyrimidine
concentration
value
molecular
S11
C6
methanol
mortality
iodinated
octanol
richard
summarized
SI
current
yasuda
expected
dihydrate
117
conclusion
jia
genomic
stu
dissolved
metabolic
yoshimura
heelan
lux
muslim
variou
tagrisso
creative
les
material
tube
zhang
F3
threonine
SLC
2188
nitrophenyl
proton
103
kinase
into
0178
derived
texa
matsuda
catalysi
administration
ARC
per
yate
kurobuchi
publishing
observed
acetonitrile
nuaille
138
7010B
dojindo
450
cdcl3
medicinal
binding
H7
stehle
53508
other
cancer
guideline
number
H3255
vitro
S7
3262
selective
west
sumida
amino
labeled
melanoma
department
explain
elst
H54
reduced
fact
account
gatekeeper
average
chan
oncology
FNO3
most
meng
choi
washiyama
168
2018
acquire
kawamura
T700
NCS
513
kazuhiro
mentioned
plasma
gai
doi
exon
thr790
diphenylpyrimidine
accordance
temperature
745
rate
incubated
361
1462
bai
detection
ohmomo
iodomethane
partition
radiolabeling
carrying
400
144
frequently
elimination
SPD
expressing
counter
pyrimidine
mutated
TX
care
reaction
NIRST
tani
prevalent
122
AP
almost
ECA
compared
sumoharjo
jordan
920
introduction
achieve
curr
162
ADP
also
protocol
incidence
757
total
med
human
MPG
because
deproteinization
excretion
percent
dried
it
2017
difference
861
211
data
4584
result
394
three
waltham
bile
therapy
profile
wa
project
outstanding
glycol
kenji
PDGFRβ
than
purity
national
exist
kbq
001
reduction
CM082
maintained
16H05397
ethanol
1566
natl
3049
biodistribution
endowment
thereby
bi
evidence
modeling
merck
provided
left
monitored
acknowledgment
labenski
form
yarden
two
varella
culture
644
journal
investigate
101
CD3
lan
glo
kindly
miller
following
cytotoxicity
statistic
demonstrated
seimbille
polyethylene
T790M
O4
growth
sequist
double
akhter
image
styryl
bovine
overall
taken
institute
garcia
mechanism
vesamicol
ohashi
hirano
some
atmosphere
sequencing
tert
group
WO2015003658
instruction
synthetic
250
inhibitor
supplied
koike
toyohara
complex
detecting
acid
heart
first
conflict
crowley
started
shavrin
pancrea
activity
switzerland
maennedorf
2005
conducted
soria
468
sensitive
specificity
732
protein
windhorst
anderson
japan
zhao
acrylamide
380
madison
mediated
osaka
nonradioactive
varmu
inoculated
stirring
IC50
CC
coupled
CA
moderate
sigma
developed
cage
oashi
zhu
gazdar
mmol
although
191
reduce
hcl
padera
assessed
pickup
intestine
com
rpm
low
radiopharmaceutical
imidazol
vander
play
eisse
greatly
set
pathway
experiment
purification
function
IN2
retention
free
anhydride
despite
selectivity
epidermal
tissue
normal
exces
palpable
common
substituted
RPMI
cortot
fridge
dichloro
condenser
france
modification
sodium
prediction
disulfophenyl
biopsy
biowest
obtained
C11
display
fawwaz
colorles
bone
possible
organ
elmer
9461
vein
intratumoral
purpose
bound
pharmacy
cellular
790
mahmoud
novel
precursor
chem
act
liu
1172
decreased
intravenou
ATP
1464
0168
8555
site
rapidly
muscle
1219
tailed
CO3
develop
S4
international
977
calculated
233
condition
cultured
chain
brouwer
greater
H17
alteration
aid
lack
faculty
test
cause
acces
removed
out
computed
striking
tracer
40732
FPN
availability
mishiro
even
not
mutational
radiosynthesi
radiological
abstract
consistent
clin
conferring
center
reason
iodobenzene
namely
okazawa
yamaguchi
LPDP
ishikawa
xavier
filtration
H5
interaction
degree
nature
KM
grant
term
catalyst
walter
mouse
four
over
unstable
funding
prepared
9559
1192
sacrificed
separated
JMS
6838
potent
104
kinuya
franklin
IN4
5SL
131
met793
inadequate
would
1603
intraperitoneally
EGFRL858R
ice
briefly
H3
modified
higher
based
F254
ham
additionally
6845
EGF
dubinett
mice
potential
KRAS
dry
dongen
carbamate
inhibitory
radioactive
S8
promega
mutation
penetrate
zhou
influence
hatori
representative
intermediate
keyword
C797S
studie
qst
stability
radionuclide
adding
tomography
fibrosarcoma
1018
O2
whole
157
151
size
concentrated
125
pad
shilo
centrifuged
C4
adenocarcinoma
S2
under
discussion
inage
S6
shoulder
gradually
gel
generation
152
H6
highly
unimportant
3905
chemistry
then
muammar
1089
1186
repeated
early
gadgeel
N2
murine
ferlay
kawai
kok
9645
vivo
peak
fraction
schroeder
163766
crude
correlate
CO2
creativecommon
iodophenyl
hydrophobic
tomoike
hepatobiliary
case
supplemented
phosphate
long
used
foundation
mainly
bidentate
afatinib
product
unpaired
matsumoto
kumata
clinically
them
ogawa
kanazawa
substitution
S10
afford
suggest
background
structure
dulla
iacob
tool
oncotarget
target
dimethylacetamide
discovery
effendi
dulbecco
extracted
min
fold
draft
final
stannylated
food
introduced
mukhopadhyay
diamine
brown
2013
takarada
C16
canale
IN7
lung
susceptible
deviation
129
demonstrate
sulfuric
volgin
successfully
rosen
hybridization
synthesized
fluoro
MD
C14
prism
finally
smaill
moderately
accumulated
ICO1686
cycle
methoxyethoxy
FISH
triphosphate
supplementary
cold
designed
significance
yeh
reckamp
H2
N3
driver
attributable
crossref
C39
predicting
ding
e17
fast
trifluoromethyl
1020
WST
line
january
unique
bioorganic
sample
068
purified
gefitinib
must
constant
rambau
chirieac
right
BY
tributyltin
character
tang
2133
kit
fax
inside
mixture
slobbe
analog
S12
penetration
heterogenou
frontier
DART
SO4
continued
currently
methodology
JEOL
procedure
saline
subcutaneously
2724
kawada
uptake
114
one
re
combined
ercan
99mtc
evaluation
1577
bray
puritie
grown
ed
column
lateral
300
washed
iodo
solvent
carried
selected
nitrobenzene
singh
method
kumamoto
ficorella
172
quenched
cpm
nonspecific
115
body
above
magnetic
grist
along
influenced
important
displayed
dichloromethane
1404
poot
6364
thin
yun
increased
need
primary
molecule
platelet
monkey
meanwhile
determine
field
jalving
license
rodriquez
ministry
liang
reported
kept
presented
acetic
5C18
terumo
nanogel
patient
lee
compound
naoh
yoshimoto
mutant
yan
moreover
38789
tween
koshizawa
dubrovskiy
ryuichi
monosodium
iododestannylation
3896
approved
takara
lipophilicity
considered
reagent
among
machi
plate
only
shaker
assay
developing
2014
bunn
therapie
reader
university
selecting
example
southwest
yield
treatment
lysed
weaker
chelating
tran
dioxane
bearing
reversed
3446
dual
soghomonyan
sealed
all
previously
klempner
S3
odani
domain
medical
buffered
met790
crystal
JNM
covalent
liver
372
3267
makassar
lipid
ANOVA
irreversible
yamada
137
kanto
targeted
streptomycin
auto
nukaga
balatoni
127
butanol
MA
280
resonance
detailed
intact
exhibited
necessarily
likely
watanabe
TKI
rociletinib
sport
F200
specific
commercially
osimertinib
indonesia
jiang
TFA
iodide
koura
2008
hexabutyldistannane
housed
solomon
prior
20A
chlorosuccinimide
until
bronte
4591
overnight
shown
relevant
bronchioloalveolar
subtype
2914
separation
nahco3
viability
155
summarize
found
H15
EDTA
passive
424
evolution
affinity
global
methoxyl
clinical
phenylenediamine
dziadziuszko
1070
S5
factor
silica
snapshot
represent
mbq
according
bazan
2729
permeability
every
oncol
231
acad
pure
purchased
collected
tributylstannyl
evaluate
fang
czernin
each
overexpressing
plos
jadhav
160
real
centrifugation
serum
vortexed
microplate
further
stomach
9225
injected
showed
H441
1074
receptor
completed
753
information
instead
resulting
exhibit
detected
logarithm
methoxyphenyl
formerly
2H2
filtrate
analytical
performance
report
kogawa
distributed
activated
figure
toward
ren
confirmed
significantly
acetate
solubility
encounter
wherea
ACS
fueger
mobile
same
nintedanib
springer
wako
EGFR
approximately
diisopropylethylamine
reducing
ltd
hooge
strategy
dunnett
republic
agreed
enzyme
wild
competitively
FAB
perkin
iodine
2192
investigation
2132
294
handling
industry
kiyono
targeting
evaluated
reached
stannylation
correspondence
107
gebbia
slightly
may
tyrosine
4459
vrie
bodenstein
siragusa
rep
2015
proc
9875
CT
injection
without
revolutionary
pattern
quinolin
review
version
now
3000x
S21
kakuma
potency
linker
through
biol
cuenta
inoculation
published
conceptualization
fluorescence
blood
249
sex
urip
contrast
mas
blocking
against
emission
presence
2019
radiolabeled
sulfate
index
high
2020
cell
permeation
organic
H10
hydrophobicity
passively
aimed
slight
implanted
buffer
received
radioiodinated